Abn Amro Investment Solutions Moderna, Inc. Transaction History

Abn Amro Investment Solutions

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Sep 04, 2025	BUY	$36.85 - $63.93 $65,371 - $113,411	1,774 Added 48.04%	5,467 $227 Million
Q3 2024 Sep 04, 2025	BUY	$63.64 - $125.14 $235,022 - $462,142	3,693 New	3,693 $247 Million
Q2 2024 Sep 04, 2025	BUY	$101.21 - $166.61 $434,696 - $715,589	4,295 New	4,295 $510 Million
Q2 2023 Sep 05, 2025	SELL	$118.5 - $160.53 $165,307 - $223,939	-1,395 Closed	0 $0
Q1 2023 Sep 05, 2025	BUY	$135.66 - $197.02 $189,245 - $274,842	1,395 New	1,395 $214 Million

845

258M

40.2M

44M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $9.69B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Abn Amro Investment Solutions, based on Form 13F filings with the SEC.

Stay updated on Abn Amro Investment Solutions with notifications on news.